ResearchToPractice.com/VPB210 – A 38-yo woman presents with a primary ER-negative, HER2-positive BC and hepatic and bone metastases. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB210 –A 62-yo woman has an ER+, HER2- lobular carcinoma encompassing the left breast and a right pleural effusion and peritoneal stranding on CT scan. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB210 – A 28-yo woman with a 2.5-cm, Grade II, ER/PR+, HER2- breast tumor is enrolled on the BETH trial of adjuvant chemo and trastuzumab with or without bevacizumab. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB210 – A 51-yo woman with a 3-cm, Grade II, strongly ER/PR+, HER2- IDC has 17/18 positive axillary nodes and 4 satellite breast nodules. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB210 – A 65-yo woman has bone and hepatic metastases after 4 years of treatment with adjuvant letrozole for a 1.2-cm, ER+, HER2-, node- IDC. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB210 – A case-based discussion on the management of breast cancer featuring an interview with Sandra M Swain, MD and Neelima Denduluri, MD conducted by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 67yo has a 1.3-cm, Grade II, strongly ER+, HER2- IDC with lymphovascular invasion and 1 lymph node with a 2-mm micromet and an Oncotype DX RS of 24. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 52yo premenopausal woman develops erythematous, ulcerated, ER/PR+, HER2+ BC while receiving AC>TH and tamoxifen for contralateral BC. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 77yo woman presents with a 10-cm, Grade

III, weakly ER/PR+, HER2-equivocal, node+ IDC and questionable liver and bone mets. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 50yo premenopausal woman has locally advanced ER+, HER2- IDC and widespread mets to the bone, lung and brain. Interview conducted by Neil Love, MD. Produced by Research To Practice.